Thank you! Your request has been received.
A member of our team will reach out to you shortly,
Oops! Something went wrong while submitting the form.
+
KnolScapes Simulate, validate, and accelerate drug development and market access decisions with a continuously updating, living intelligence platform.
Knolens KnolScapes streamlines drug development, regulatory planning, and commercialization strategies by delivering a continuously updated, real-time intelligence hub across clinical, HEOR, market access, and competitive intelligence functions.
KnolScapes delivers:
1. Therapy landscapes & competitive positioning
2. Disease overviews with epidemiology, prevalence, and burden insights
3. HEOR & HTA analyses to accelerate payer strategy
4. Clinical study design optimization with scenario modeling
5. Biomarker and patient outcomes tracking across 100+ indications
Whether you need pre-built analytics or custom modules aligned to your therapy area, KnolScapes provides:
✔️ 10+ Specialized Modules across the full drug development value chain
✔️ 50+ Deep-Dive Panels delivering real-time insights
✔️ Continuous Auto-Updates with the latest research, trials, and approvals
✔️ Configurable Frameworks adaptable by function, region, or project scope
Accelerate regulatory approvals, optimize market and trial strategies, and deliver decision-ready insights—all through a continuously updating, compliance-ready intelligence platform.
Therapy-focused modules deliver fast, evidence-based insights across disease burden, epidemiology, and treatment evolution.
Auto-updates from global sources and extends seamlessly to custom therapeutic or functional modules
Customize the platform with modules tailored to your disease area or functional needs.
Identify the drivers of regulatory and payer decisions across markets—aligning trial design, evidence generation, and pricing models.
Evaluate patient outcomes, target and mechanism scoring, and cost-effectiveness benchmarks to strengthen payer negotiations and guideline alignment.
Compare outcomes by target, trial size, MoA, and treatment line to assess real-world impact.
Generate bespoke analysis across internal and relevant public data sources.
Analyze market positioning, HTA precedents, reimbursement signals, and value drivers to shape successful global access strategies.
KnolScapes applies semantic AI for context-aware analysis, with on-demand revisions to reflect evolving data.
Refresh or re-run analysis instantly to reflect the latest decisions or data changes — no rework needed.
Understand what influences regulatory and payer decisions across global markets.
Compare outcomes by drug class, study design, and treatment sequence to support HEOR and value narratives.
Prioritize targets and mechanisms of action based on clinical differentiation and market acceptance benchmarks.
Evaluate asset positioning against payer thresholds and QALY-based value frameworks.
Whether mapping therapy landscapes, tracking disease evolution, assessing biomarker performance, or evaluating patient outcomes, KnolScapes delivers real-time precision, scientific depth, and regulatory-grade rigor—driving smarter, faster, and more confident decisions across the drug development lifecycle.
